Research Publications

Aspirin with bypass surgery--from taboo to new standard of care.

Topol EJ

Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model.

Zhou Z, Penn MS, Forudi F, Zhou X, Tarakji K, Topol EJ, Lincoff AM, Wang K

The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIb.

Lee MS, Wali AU, Menon V, Berkowitz SD, Thompson TD, Califf RM, Topol EJ, Granger CB, Hochman JS

Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability.

Mehta RH, Criger DA, Granger CB, Pieper KK, Califf RM, Topol EJ, Bates ER

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.

Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ

Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile.

Kereiakes DJ, Lincoff AM, Anderson KM, Achenbach R, Patel K, Barnathan E, Califf RM, Topol EJ, EPIC Investigators, EPILOG investigators, EPISTENT investigators

Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy.

Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ

Genetic testing for coronary heart disease: the approaching frontier.

Agah R, Topol EJ

The role of low-molecular-weight heparin in cardiovascular diseases.

Mukherjee D, Topol EJ

Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention.

Chan AW, Quinn MJ, Bhatt DL, Chew DP, Moliterno DJ, Topol EJ, Ellis SG